Document:

Exhibit 10.2

 

AGILENT
TECHNOLOGIES, INC.

1999
NON-EMPLOYEE DIRECTOR STOCK PLAN

STOCK
OPTION AWARD AGREEMENT

 

THIS AGREEMENT, dated  as of the date of
grant (the “Grant Date”) indicated in your account maintained by the
company providing administrative services in connection with the Plan (as
defined below) (the “External Administrator”), between Agilent Technologies, Inc.,
a Delaware corporation (the “Company”), and you as an individual who has been
granted a stock option pursuant to the Agilent Technologies, Inc. 1999 Non-Employee
Director Stock Plan (the “Awardee”) is entered into as follows:

 

WITNESSETH:

 

WHEREAS, the Company has
established the Agilent Technologies, Inc. 1999 Non-Employee Director Stock
Plan, as amended and restated effective (the “Plan”), and a description of the
terms and conditions of the Plan is set forth in the U.S. Plan prospectus (the “Prospectus”).  A copy of each of the Plan document and Prospectus
is available on your External Administrator website and will also be made
available upon request; and

 

WHEREAS, the Compensation
Committee of the Board of Directors of the Company (the “Committee”) or its
authorized delegate(s) determined that the Awardee shall be granted an
option under the Plan as hereinafter set forth;

 

NOW THEREFORE, the
parties hereby agree that the Company grants the Awardee an option (“Option”) subject
to the terms and conditions set forth herein and in the Plan to purchase the
number of shares of the Company’s $0.01 par value voting Common Stock indicated
in the Awardee’s External Administrator account, or if this Agreement is
delivered in hardcopy, is set forth here: 
Grant Date             ;
Option price $              ;
Number of shares               .

 

1.                    Governing
Document.  This Option is granted under and pursuant to
the Plan and is subject to each and all of the provisions thereof.  In the event of a conflict between the terms
and conditions of the Plan and the terms and conditions of this Award
Agreement, the terms and conditions of the Plan shall prevail.  Capitalized terms used and not otherwise
defined herein are used with the same meanings as in the Plan.

 

2.                    Option
Price.  The Option price shall be  equal to the Fair Market Value (as defined in
the Plan document) of the underlying shares on the Grant Date, unless otherwise
required by law.  The Option price for
this grant is indicated in the Awardee’s External Administrator account.

 

3.                    Non-Transferability of Option.  This Option
is not transferable by the Awardee except by will
or the laws of descent and distribution. During the Awardee’s lifetime, only
the Awardee can exercise this Option. 
This Option may not be transferred, assigned, pledged or hypothecated by
the Awardee during his or her lifetime, whether by operation of law or
otherwise, and is not subject to execution, attachment or similar process.

 

4.                    Vesting.  Subject to accelerated vesting upon the
occurrence of certain events as set forth in the Plan, this Option will vest in
whole or in part, in accordance with the following vesting schedule:  This option is exercisable in four 25%
increments with the first vesting date on the date of the annual shareholders
meeting following the Grant Date, provided that the Director continues as a
member of the Board. The second, third and fourth vesting dates shall be the
dates six months, nine months and one year, respectively, following the Grant
Date, provided the Director continues as a member of the Board of Directors of
the Company on the vesting date.

 

5.                    Term
of the Option.  This Option will expire ten (10) years
from the Grant Date, unless sooner terminated, forfeited, or canceled in
accordance with the provisions of the Plan. 
This means that the Option must be exercised, if at all, on or before
the expiration date.  This expiration
date is indicated in the Awardee’s External Administrator account.  The Awardee is responsible for keeping track
of this date and will not receive any prior notification of the expiration date
from the Company.  All rights of the
Awardee in this Option, to the extent that it has not been exercised, shall
terminate effective upon the removal of the Director from the Agilent Board of
Directors for Cause (as defined under Delaware law).

 

6.                    Exercise
of the Option.  Options may be exercised in any manner
permitted by the External Administrator, and will be subject to such
administrator’s fees and procedures.  The
Company reserves the right to limit availability of certain methods of exercise
as it deems necessary, including those limitations set forth in any Appendix to
this Award Agreement.

 

7.                    Death
of Awardee.  All rights of the Awardee in this Option, to
the extent that it has not been exercised, shall terminate upon the death of
the Awardee, except as hereinafter provided. 
The Awardee may, by written notice to the company, designate one or more
persons, including his or her legal representative, who shall by reason of the 

 

1

 

Awardee’s death acquire
the right to exercise all or a portion of the Awardee’s Option.  The person so designated must exercise the
Option within the term of the Option as set forth in the Plan.  The person designated to exercise the Option
after the Awardee’s death shall be bound by the provisions of the Plan.

 

8.                    Restrictions on Sale of Shares of Common Stock.  The
Company shall not be obligated to issue any shares of Common Stock pursuant to
this Option unless the shares of Common Stock are at that time effectively
registered or exempt from registration under the U.S. Securities Act of 1933,
as amended, and, as applicable, local laws.

 

9.                    Responsibility
for Taxes.  Regardless of any action the Company takes
with respect to any or all income tax, social insurance, payroll tax or other
tax-related withholding (the “Tax-Related Items”), the Awardee acknowledges
that the ultimate liability for all Tax-Related Items legally due by the Awardee
is and remains the Awardee’s responsibility and that the Company (1) make
no representations or undertakings regarding the treatment of any Tax-Related
Items in connection with any aspect of the Option, including the grant, vesting
or exercise of the Option, the subsequent sale of shares of Common Stock acquired
pursuant to such exercise and the receipt of any dividends; and (2) do not
commit to structure the terms of the grant or any aspect of the Option to
reduce or eliminate the Awardee’s liability for Tax-Related Items.

 

Prior to the relevant taxable event, the
Awardee shall pay or make adequate arrangements satisfactory to the Company to
satisfy all Tax-Related Items withholding obligations of the Company.  In this regard, the Awardee authorizes the
Company, at its sole discretion to satisfy the obligations with regard to all
applicable Tax-Related Items legally payable by one or a combination of the
following: (1) withholding from the Awardee’s wages or other cash
compensation paid to the Awardee by the Company; (2) withholding from
proceeds of the sale of shares of Common Stock acquired upon exercise of the
Option; (3) arranging for the sale of shares of Common Stock acquired upon
exercise of the Option (on the Awardee’s behalf and at the Awardee’s discretion
pursuant to this authorization); or (4) withholding in shares of Common
Stock, provided that the Company only withholds the amount of shares of Common
Stock necessary to satisfy the minimum withholding amount.  If the obligation for the Awardee’s
Tax-Related Items is satisfied by withholding a number of shares of Common
Stock as described herein, the Awardee is deemed to have been issued the full
number of shares of Common Stock subject to the Option, notwithstanding that a
number of the shares of Common Stock are held back solely for the purpose of
paying the Tax-Related Items due as a result of any aspect of this Option.

 

Finally, the Awardee will pay to the Company
any amount of Tax-Related Items that the Company may be required to withhold as
a result of the Awardee’s participation in the Plan or the Awardee’s purchase
of shares of Common Stock that cannot be satisfied by the means previously
described.  The Company may refuse to
honor the exercise and refuse to deliver the shares of Common Stock if the
Awardee fails to comply with his or her obligations in connection with the
Tax-Related Items as described in this section.

 

10.              Adjustment.  The number of shares of Common Stock subject
to this Option and the Option price of such shares may be adjusted by the
Company from time to time pursuant to the Plan.

 

11.              Nature
of the Option.  By accepting the grant of this Option, the Awardee
acknowledges and agrees that:

 

(i)                           the
Plan is established voluntarily by the Company, it is discretionary in nature
and it may be modified, amended, suspended or terminated by the Company at any
time, unless otherwise provided in the Plan and this Award Agreement;

 

(ii)                        the
grant of an option is a one-time benefit which does not create any contractual
or other right to receive future grants of options, or benefits in lieu of
options, even if options have been granted repeatedly in the past;

 

(iii)                     all
determinations with respect to any future option grants, including, but not
limited to, the times when options shall be granted, the maximum number of
shares subject to each option and the option price, will be at the sole
discretion of the Company;

 

(iv)                    participating
in the Plan is voluntary;

 

(v)                       in
the event the Awardee is not an employee of the Company, the Option will not be
interpreted to form an employment contract or relationship with the Company,
the Employer or any Subsidiary or Affiliate;

 

(vi)                    the
future value of the underlying shares of Common Stock is unknown and cannot be
predicted with certainty;

 

(vii)                 if
the underlying shares of Common Stock do not increase in value, the Option will
have no value;

 

(viii)              if
the Awardee exercises the Option and acquires shares of Common Stock, the value
of those shares of Common Stock acquired may increase or decrease in value,
even below the Option price;

 

(ix)                      the
vesting of any Option ceases upon termination of Director statues with the
Company, or other cessation of eligibility to vest for any reason, except as
may otherwise be explicitly provided in the Plan document or this Award
Agreement;

 

2

 

(x)                         the
Company is not providing any tax, legal or financial advice, nor is the Company
making any recommendations regarding the Awardee’s participation in the Plan,
the exercise of the Option or the purchase or sale of shares of Common Stock
under the Plan;

 

(xi)                      the
Awardee is advised to consult with personal tax, legal and financial advisors
regarding participation in the Plan before taking any action related to the
Plan.

 

12.            Data Privacy.  The  Awardee explicitly
and unambiguously consents to the collection, use and transfer, in electronic
or other form, of the Awardee’s personal data as described in this document by
and among, as applicable, the Company and the External Administrator  for the exclusive purpose of implementing,
administering and managing the Awardee’s participation in the Plan.

 

The Awardee hereby understands that the
Company and hold certain personal information about the Awardee, including, but
not limited to, the Awardee’s name, home address and telephone number, date of
birth, social security number or other identification number, salary,
nationality, job title, any shares of stock or directorships held in the
Company, details of all Options or any other entitlement to shares of Common
Stock awarded, canceled, exercised, vested, unvested or outstanding in the
Awardee’s favor, for the purpose of implementing, administering and managing
the Plan (“Data”).  The Awardee hereby
understands that Data may be transferred to any third parties (including the
External Administrator) assisting in the implementation, administration and
management of the Plan, that these recipients may be located in the Awardee’s
country or elsewhere, such as outside the European Economic Area, and that the
recipient’s country may have different data privacy laws and protections than
the Awardee’s country.  All such
transfers of Data will be in accordance with the Company’s Privacy Policies and
Guidelines.  The Awardee hereby
understands that the Awardee may request a list with the names and addresses of
any potential recipients of the Data by contacting the Awardee’s local human
resources representative.  The Awardee
authorizes the recipients to receive, possess, use, retain and transfer the
Data, in electronic or other form, for the purposes of implementing,
administering and managing the Awardee’s participation in the Plan, including
any requisite transfer of such Data as may be required to a broker or other
third party with whom the Awardee may elect to deposit any Common Stock
acquired upon exercise of the Option. 
The Awardee hereby understands that refusing or withdrawing the Awardee’s
consent may affect the Awardee’s ability to participate in the Plan.  For more information on the consequences of
the Awardee’s refusal to consent or withdrawal of consent, the Awardee
understands that he or she may contact his or her human resources
representative responsible for the Awardee’s country at the local or regional
level.

 

13.              No
Rights Until Issuance.  The Awardee shall have no rights hereunder as
a shareholder with respect to any shares subject to this Option until the date
that shares of Common Stock are issued to the Awardee upon exercise of the
Option.

 

14.              Administrative Procedures. 
The
Awardee agrees to follow the administrative procedures that may be established
by the Company and/or the External Administrator for participation in the Plan
which may include a requirement that the shares issued upon vesting be held by
the External Administrator until the Awardee disposes of such shares.  The Awardee further agrees that the Company
may determine the actual method of withholding for Tax-Related Items as
described in Section 9 above.

 

15.              Entire
Agreement; Amendment.  The Plan is incorporated herein by
reference.  The Plan and this Award
Agreement constitute the entire agreement of the parties with respect to the
subject matter hereof and supersede in their entirety all prior undertakings
and agreements of the Company and the Awardee with respect to the subject
matter hereof, and may not be modified adversely to the Awardee’s interest
except by means of a writing signed by the Company and the Awardee.  Otherwise, this Option may be amended as
provided in the Plan.

 

16.              Governing
Law and Venue.  This Award Agreement is governed by and
construed according to the internal substantive laws, but not the choice of law
rules, of the State of Delaware as provided in the Plan.  Any proceeding arising out of or relating to
this Award Agreement or the Plan may be brought only in the state or federal
courts located in the Northern District of California where this grant is made
and/or to be performed, and the parties to this Award Agreement consent to the
exclusive jurisdiction of such courts.

 

17.              Binding
Agreement; Interpretation.  By accepting the grant of this Option
evidenced hereby, the Awardee and the Company agree that this Option is granted
under and governed by the terms and conditions of the Plan and this Award
Agreement.  The Awardee has reviewed the
Prospectus and this Award Agreement in their entirety, has had an opportunity
to obtain the advice of counsel prior to accepting the Option and fully
understands all provisions of the Prospectus and Award Agreement.  The Awardee agrees to accept as binding,
conclusive and final all decisions or interpretations of the Administrator upon
any questions relating to the Plan and Award Agreement.

 

18.              Language.  The Awardee acknowledges that he or she may
be executing part or all of the Award Agreement in English and agrees to be
bound accordingly.  If the Awardee has
received this or any other document related to the 

 

3

 

Plan translated into a
language other than English and if the translated version is different than the
English version, the English version will control.

 

19.              Electronic
Delivery.  The Company may, in its sole discretion,
decide to deliver any documents related to the Option granted under (and
participation in) the Plan or future awards that may be granted under the Plan
by electronic means or to request the Awardee’s consent to participate in the
Plan by electronic means.  The Awardee hereby consents to receive such documents
by electronic delivery and, if requested, to agree to participate in the Plan
through an on-line or electronic system established and maintained by the
Company or another third party designated by the Company.

 

20.              Severability.  The provisions of this Award Agreement are
severable and if any one or more provisions are determined to be illegal or
otherwise unenforceable, in whole or in part, the remaining provisions shall
nevertheless be binding and enforceable.

 

21.              Acceptance
and Rejection.  This Award Agreement is one of
the documents governing this Option, which the Awardee may accept or reject
online through the External Administrator’s website.  The Awardee may also accept this Option by
signing a hard copy of the Award Agreement and returning it to the Company’s
Shareholder Records department, fax number (408) 345-8237.

 

 

	
   

  	
  Agilent
  Technologies, Inc.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By

  	
  /s/ William P. Sullivan

  
	
   

  	
   

  	
  William P. Sullivan

  
	
   

  	
   

  	
  President and Chief Executive Officer

  
	
   

  	
   

  
	
   

  	
  By

  	
  /s/ D. Craig Nordlund

  
	
   

  	
   

  	
  D. Craig Nordlund

  
	
   

  	
   

  	
  Senior Vice President, General Counsel
  and Secretary

  
	
   

  	
   

  

 

	
  Accepted
  By:

  	
   

  	
  , Director
  Awardee

  
	
   

  	
   

  	
   

  
	
  Print
  Name:

  	
   

  	
   

  

 

 

The
Director hereby designates the following person(s) as the one(s) who
may exercise this Option after his or her death as provided above:

 

 

	
  Name:

  	
   

  	
   

  	
  Relationship:

  	
   

  
	
   

  	
   

  
	
  Name:

  	
   

  	
   

  	
  Relationship:

  	
   

  

 

 

The Director may change the above designation at his
or her pleasure by filing with the Secretary of the Company a written notice of
change.

 

PLEASE
PRINT AND KEEP A COPY FOR YOUR RECORDS

 

4Exhibit
10.6

 

EXECUTION
COPY

 

FIFTH
AMENDED AND RESTATED RELATED AGREEMENT

 

This Fifth Amended and Restated Related Agreement,
dated as of August 7, 2008 (this “Agreement”), is made by and among
MERRILL LYNCH CAPITAL SERVICES, INC., a corporation organized under the laws of
the State of Delaware (“Merrill Lynch”), AGILENT TECHNOLOGIES, INC., a
corporation organized under the laws of the State of Delaware (“Agilent”),
and AGILENT TECHNOLOGIES WORLD TRADE, INC., a corporation organized under the
laws of the State of Delaware (“World Trade”).

 

RECITALS

 

WHEREAS, Fenway Capital, LLC (“Fenway”) and
World Trade were parties to that certain Master Repurchase Agreement, and the
Confirmation and Annex I related thereto, in each case, dated as of January 27,
2006 (such master repurchase agreement, confirmation and annex, as the same may
be amended, amended and restated, supplemented or otherwise modified from time
to time, being collectively referred to as the “Original Repo Agreement”);

 

WHEREAS, in connection with the Original Repo
Agreement, Agilent issued that certain Guaranty of Agilent Technologies, Inc.,
dated as January 27, 2006 (as amended, amended and restated, supplemented
or otherwise modified from time to time, the “Original Agilent Guaranty”),
whereby Agilent agreed to guarantee the obligations of World Trade under the
Original Repo Agreement;

 

WHEREAS, in connection with the Original Repo
Agreement, Fenway entered into that certain Amended and Restated Institutional
Custody and Escrow Agreement, dated as of February 10, 2006 with The Bank
of New York, as custodian, pursuant to which the Purchased Securities were
deposited in a custody account maintained by The Bank of New York for the
benefit of Fenway;

 

WHEREAS, Merrill Lynch and Fenway entered into that
certain ISDA Master Agreement and the confirmation and schedule related
thereto, in each case, dated as of January 27, 2006 (such master
agreement, confirmation and schedule being collectively referred to as the “Original
Liquidity Arrangement”);

 

WHEREAS, Merrill Lynch, Agilent and World Trade
entered into that certain Related Agreement dated as of January 27, 2006
(the “Original Related Agreement”) whereby Merrill Lynch, Agilent and
World Trade agreed to certain matters with respect to the transactions contemplated
by the Original Repo Agreement and the Original Liquidity Arrangement;

 

WHEREAS, Fenway assigned to Ebbets Funding PLC (“Ebbets”)
all of Fenway’s rights, duties and obligations under the Original Repo
Agreement and the Original Agilent Guaranty pursuant to that certain Novation
Agreement among Fenway, Ebbets and World Trade dated as of September 10,
2007 (the “First Repo Novation Agreement”);

 

WHEREAS, pursuant to the terms of the First Repo
Novation Agreement, Ebbets and World Trade entered into a new Master Repurchase
Agreement, and the Confirmation and 

 

 

Annex I related
thereto, in each case, dated as of September 10, 2007 (such master
repurchase agreement, confirmation and annex, as the same may be amended,
amended and restated, supplemented or otherwise modified from time to time,
being collectively referred to as the “Ebbets Repo Agreement”);

 

WHEREAS, in connection with the First Repo Novation
Agreement and the Ebbets Repo Agreement, Agilent issued that certain Amended
and Restated Guaranty of Agilent Technologies, Inc., dated as of September 10,
2007 (as amended, amended and restated, supplemented or otherwise modified from
time to time, the “First A&R Agilent Guaranty”), whereby Agilent
agreed to guarantee the obligations of World Trade under the Ebbets Repo
Agreement;

 

WHEREAS, in connection with the Ebbets Repo
Agreement, Ebbets entered into that certain Institutional Custody and Escrow
Agreement, dated as of September 10, 2007, with The Bank of New York, as
custodian (as amended, amended and restated, supplemented or otherwise modified
from time to time, the “Ebbets Custody Agreement”), pursuant to which
the Purchased Securities were deposited in a custody account maintained by The
Bank of New York for the benefit of Ebbets;

 

WHEREAS, in connection with the Ebbets Repo
Agreement, Merrill Lynch and Ebbets entered into that certain ISDA Master
Agreement and the confirmation (the “Ebbets LA Confirmation”) and
schedule related thereto, in each case, dated as of September 7, 2007
(such master agreement, the Ebbets LA Confirmation and such schedule being
collectively referred to as the “Ebbets Liquidity Arrangement”);

 

WHEREAS, Merrill Lynch, Agilent and World Trade
entered into that certain Amended and Restated Related Agreement dated as of September 10,
2007 (the “First A&R Related Agreement”) whereby Merrill Lynch,
Agilent and World Trade agreed to certain matters with respect to the
transactions contemplated by the Ebbets Repo Agreement and the Ebbets Liquidity
Arrangement;

 

WHEREAS, Ebbets assigned to Belmont Funding LLC (“Belmont”)
all of Ebbets’s rights, duties and obligations under the Ebbets Repo Agreement
and the First A&R Agilent Guaranty pursuant to that certain Novation
Agreement among Ebbets, Belmont and World Trade dated as of November 16,
2007 (the “Second Repo Novation Agreement”);

 

WHEREAS, pursuant to the terms of the Second Repo
Novation Agreement, Belmont and World Trade entered into a new Master
Repurchase Agreement, and the Confirmation and Annex I related thereto, in
each case, dated as of November 16, 2007 (such master repurchase
agreement, confirmation and annex, as the same may be amended, amended and
restated, supplemented or otherwise modified from time to time, being
collectively referred to as the “Belmont Repo Agreement”);

 

WHEREAS, in connection with the Second Repo Novation
Agreement and the Belmont Repo Agreement, Agilent issued that certain Second
Amended and Restated Guaranty of Agilent Technologies, Inc., dated as of November 16,
2007 (as amended, amended and restated, supplemented or otherwise modified from
time to time, the “Second A&R Agilent Guaranty”), 

 

2

 

whereby Agilent agreed to
guarantee the obligations of World Trade under the Belmont Repo Agreement;

 

WHEREAS, in connection with the Belmont Repo
Agreement, Belmont entered into that certain Institutional Custody and Escrow
Agreement, dated as of November 16, 2007, with The Bank of New York, as
custodian (as amended, amended and restated, supplemented or otherwise modified
from time to time, the “Belmont Custody Agreement”), pursuant to which
the Purchased Securities were deposited in a custody account maintained by The
Bank of New York for the benefit of Counterparty;

 

WHEREAS, in connection with the Belmont Repo
Agreement, Merrill Lynch and Belmont entered into that certain ISDA Master
Agreement and the confirmation (the “LA Confirmation”) and schedule
related thereto, in each case, dated as of November 16, 2007 (such master
agreement, the LA Confirmation and such schedule being collectively referred to
as the “Liquidity Arrangement”);

 

WHEREAS, Merrill Lynch, Agilent and World Trade
entered into that certain Amended and Restated Related Agreement dated as of November 16,
2007 (the “Second A&R Related Agreement”) whereby Merrill Lynch,
Agilent and World Trade agreed to certain matters with respect to the
transactions contemplated by the Repo Agreement and the Liquidity Arrangement,
which Second A&R Related Agreement was amended and restated as of December 7,
2008 (the “Third A&R Related Agreement”);

 

WHEREAS, on March 17, 2008, a Liquidation Period End Date (as
defined in the LA Confirmation) occurred and Merrill Lynch tendered in cash all
amounts required to be paid to Belmont pursuant to the terms of the Liquidity
Arrangement and, on March 19, 2008, Merrill Lynch delivered notification
pursuant to the Third A&R Related Agreement to Agilent and World Trade of
the foregoing occurrences and certain other matters;

 

WHEREAS, Belmont assigned to STEERS Repo Pass-Thru
Trust, 2008-1 (“Counterparty”) all of Belmont’s rights, duties and
obligations under the Belmont Repo Agreement and the Second A&R Agilent
Guaranty pursuant to that certain Novation Agreement among Belmont,
Counterparty and World Trade dated as of March 17, 2008 (the “Third
Repo Novation Agreement”);

 

WHEREAS, pursuant to the terms of the Third Repo
Novation Agreement, Counterparty and World Trade entered into a new Master
Repurchase Agreement, and the Confirmation and Annex I related thereto, in
each case, dated as of March 17, 2008 (such master repurchase agreement,
confirmation and annex, as the same may be amended, amended and restated,
supplemented or otherwise modified from time to time, being collectively
referred to as the “Repo Agreement”);

 

WHEREAS, in connection with the Third Repo Novation
Agreement and the Repo Agreement, Agilent issued that certain Third Amended and
Restated Guaranty of Agilent Technologies, Inc., dated as of March 17,
2008 (as amended, amended and restated, supplemented or otherwise modified from
time to time, the “Third A&R Agilent Guaranty”), whereby Agilent
agreed to guarantee the obligations of World Trade under the Repo Agreement;

 

3

 

WHEREAS, in connection with the Repo Agreement,
Counterparty entered into that certain Institutional Custody and Escrow
Agreement, dated as of June 27, 2008, with The Bank of New York, as
custodian (as amended, amended and restated, supplemented or otherwise modified
from time to time, the “Custody Agreement”), pursuant to which the
Purchased Securities were deposited in a custody account maintained by The Bank
of New York for the benefit of Counterparty;

 

WHEREAS, Merrill Lynch, Agilent and World Trade
entered into that certain Amended and Restated Related Agreement dated as of June 27,
2008 (the “Fourth A&R Related Agreement”) whereby Merrill Lynch,
Agilent and World Trade agreed to certain matters with respect to the
transactions contemplated by the Repo Agreement;

 

WHEREAS, Merrill Lynch, Agilent and World Trade now
wish to amend the Fourth A&R Related Agreement in the manner set forth
herein;

 

NOW, THEREFORE, in consideration of the promises and
mutual agreements contained herein, and of other good and valuable
consideration the receipt and sufficiency of which are hereby acknowledged, the
parties hereby agree to amend and restate the Fourth A&R Related Agreement
in its entirety as follows:

 

1.             Definitions.  All capitalized terms used but not otherwise
defined herein shall have the meanings assigned thereto in the Repo Agreement.

 

2.             Accelerated Repurchase Date.  Agilent, World Trade and Merrill Lynch (x) acknowledge
that on March 18, 2008 Merrill Lynch delivered a Merrill Lynch
Acceleration Notice to World Trade pursuant to the Third A&R Related
Agreement, which Merrill Lynch Acceleration Notice designated July 16,
2008 as the Related Agreement Accelerated Repurchase Date (as defined in the
Third A&R Related Agreement) with respect to all of the Purchased
Securities, (y) agree that World Trade is deemed to have promptly
designated July 16, 2008 as the Accelerated Repurchase Date with respect
to all of the Purchased Securities in accordance with the terms of the Belmont
Repo Agreement and the Third A&R Related Agreement and (z) agree that,
notwithstanding such Merrill Lynch Acceleration Notice, the Accelerated
Repurchase Date and the Related Agreement Accelerated Repurchase Date with
respect to all of the Purchased Securities shall be November 17, 2008,
except as otherwise provided in this Section 2.  In addition, Merrill Lynch, Agilent and World
Trade agree that World Trade shall have the right, by providing written notice
to Merrill Lynch (a “World Trade Acceleration Notice”) no later than August 14,
2008, to designate September 19, 2008 as the Accelerated Repurchase Date
with respect to all of the Purchased Securities.  In the event that World Trade shall not have
designated September 19, 2008 as the Accelerated Repurchase Date in
accordance with the preceding sentence, then World Trade shall have the right,
by providing a World Trade Acceleration Notice to Merrill Lynch no later than September 15,
2008, to designate October 20, 2008 as the Accelerated Repurchase Date
with respect to all of the Purchased Securities.  Agilent and World Trade agree that neither of
them shall designate a Partial Accelerated Repurchase Date or an Accelerated
Repurchase Date, nor otherwise voluntarily cause a Repurchase Date to occur,
except in accordance with this Section 2 or as may be otherwise consented
to by Merrill Lynch in its sole discretion.

 

4

 

3.             Assignment of the Counterparty’s
Repo Rights and Obligations; Acceleration Instruction.  Agilent and World Trade jointly and severally
agree that World Trade shall not (a) withhold consent to the assignment by
the Counterparty of the Counterparty’s Repo Rights and Obligations to Merrill
Lynch or any of its affiliates, or (b) unreasonably withhold consent to
the assignment by the Counterparty of the Counterparty’s Repo Rights and
Obligations to a third-party transferee selected by Merrill Lynch; provided,
however, that Merrill Lynch shall neither cause nor permit the Repo
Rights and Obligations to be assigned or syndicated to more than five
third-party transferees and, provided, further, that
Merrill Lynch shall neither cause nor permit the Repo Rights and Obligations to
be assigned or syndicated to any transferee if such assignment or syndication
would result in Agilent or World Trade becoming obligated both (i) to
withhold amounts in respect of U.S. withholding tax and (ii) to gross-up
or otherwise compensate Counterparty or any third-party transferee of
Counterparty in respect of such U.S. withholding tax.  Agilent and World Trade acknowledge
and agree that the sale, pledge or other transfer of securities or certificates
issued by Counterparty (such securities or certificates, “Trust Securities”)
shall not constitute an assignment or syndication of the Repo Rights and
Obligations for purposes of this Section 3 or require the consent of
Agilent or World Trade; provided that such sale, pledge or other transfer of
the Trust Securities does not cause the Counterparty to no longer be considered
a US person for U.S. federal income tax purposes.

 

Upon (x) the
fulfillment of the requisite conditions set forth in clauses (A) and (B) of
Subsection 2(f)(ii) of the Custody Agreement and (y) the designation
in writing by Agilent or World Trade to Merrill Lynch of the information
required to be provided by Merrill Lynch in the instructions described in
clause (C) of such Subsection 2(f)(ii), Merrill Lynch shall, within one
Business Day, deliver an MLCS Repurchase Notice (as defined in the Custody
Agreement) and a related share transfer form, in each case, in conformity with
the foregoing instructions, to The Bank of New York (or any replacement
custodian under the Custody Agreement) pursuant to Subsection 2(f)(ii) of
the Custody Agreement.

 

In addition, Merrill Lynch agrees not to cause,
permit or consent to any amendment to or modification of Section 2(e) or
(f) of the Custody Agreement without the written consent of Agilent or
World Trade (such consent not to be unreasonably withheld).

 

4.             Expense Reimbursement.  Each of Agilent, World Trade and Merrill
Lynch agrees that any and all expenses incurred by Merrill Lynch pursuant to Section 4(c) of
the Custody Agreement shall be promptly reimbursed by Agilent upon presentation
by Merrill Lynch of an itemized accounting thereof.

 

5.             Indemnification; Contribution.  Agilent and World Trade jointly and severally
agree to indemnify and hold harmless Merrill Lynch and its affiliates,
directors, officers, employees, agents and controlling persons (Merrill Lynch
and each such other person being an “Indemnified Party”) from and against any
and all losses, claims, damages and liabilities, joint or several, to which
such Indemnified Party becomes subject under any applicable law, or otherwise
related to or arising out of or in connection with (a) any transaction
contemplated by this Agreement, and (b) any untrue statement or alleged
untrue statement of a material fact contained in any information (whether oral
or written) or documents furnished or made available by World Trade or Agilent
or any of their affiliates in connection with any transaction contemplated
pursuant to this Agreement or the omission or the alleged omission to state
therein a material fact necessary in order to make the statements therein not
misleading, in light of the circumstances 

 

5

 

under which
they were made; provided, however, that neither Agilent nor World
Trade shall be liable, in the case of this clause (b), to the extent that
any such losses, claims, damages or liabilities arise out of or are based on
such untrue statement or alleged untrue statement or omission or alleged
omission made therein in reliance upon and in conformity with written
information relating to Merrill Lynch (or the relevant affiliate thereof)
furnished to Agilent or World Trade by Merrill Lynch expressly for use
therein.  In no event shall Agilent or
World Trade be liable for fees and expenses of more than one counsel (in
addition to any local counsel) separate from their own counsel for all
Indemnified Parties in connection with any one action or separate but similar
or related actions in the same jurisdiction arising out of the same general
allegations or circumstances.  Agilent
and World Trade jointly and severally agree to promptly reimburse any
Indemnified Party for all expenses (including reasonable counsel fees and
expenses) as they are incurred in connection with the investigation of,
preparation for or defense of any pending or threatened claim or any action or
proceeding arising from any of the matters referred to in the preceding
sentence, whether or not such Indemnified Party is a party and whether or not
such claim, action or proceeding is initiated or brought by or on behalf of
World Trade or Agilent or the relevant issuer or whether or not resulting in
any liability.  Neither Agilent nor World
Trade shall be liable for any settlement of any proceeding effected without its
written consent, but if settled with such consent or if there shall be a final
judgment for the plaintiff, Agilent and World Trade jointly or severally agree
to indemnify the Indemnified Party from and against any loss or liability by
reason of such settlement or judgment. 
Agilent and World Trade further jointly and severally agree not to
assert any claim against any Indemnified Party for consequential, punitive or
exemplary damages on any theory of liability in connection with the
transactions described in or contemplated by this Agreement.  Neither Agilent nor World Trade shall be
liable to an Indemnified Party under clause (a) of the foregoing
indemnification provision to the extent that any loss, claim, damage, liability
or expense is finally determined by a court of competent jurisdiction to have
resulted primarily from such Indemnified Party’s bad faith, gross negligence or
willful misconduct.

 

If the indemnification of an Indemnified Party
provided for in this Agreement is for any reason held unenforceable, Agilent
and World Trade jointly and severally agree to contribute to the losses,
claims, damages or liabilities for which such indemnification is held
unenforceable (a) in such proportion as is appropriate to reflect the
relative benefits to World Trade and Agilent, on the one hand, and Merrill
Lynch, on the other hand, of the relevant transaction contemplated pursuant to
this Agreement, or (b) (but only if) the allocation provided for in
clause (a) is for any reason prohibited by law, in such proportion as
is appropriate to reflect not only the relative benefits referred to in
clause (a) but also World Trade and Agilent’s relative fault, on the
one hand, and the relative fault of Merrill Lynch, on the other hand, as well
as any other relevant equitable considerations. 
Agilent and World Trade jointly and severally agree that for the
purposes of this paragraph the relative benefits to World Trade and Agilent, on
the one hand, and to Merrill Lynch, on the other hand, shall be deemed to be in
the same proportion that the total value received or contemplated to be
received by World Trade and/or Agilent in any transactions contemplated
pursuant to this Agreement bears to the fees paid or to be paid to Merrill
Lynch with respect to such transaction; provided, however, that,
to the extent permitted by applicable law, in no event shall the Indemnified
Parties be required to contribute in respect of a specific transaction an
aggregate amount in excess of the fees actually paid in such transaction to
Merrill Lynch.  The foregoing
contribution agreement shall be in addition to any rights that any Indemnified
Party may have at common law or otherwise. 
No investigation or 

 

6

 

failure to investigate by
any Indemnified Party shall impair the foregoing indemnification and
contribution agreement or any other right an Indemnified Party may have.

 

Agilent and World Trade jointly and severally agree
that, without Merrill Lynch’s prior written consent, neither World Trade nor
Agilent nor any of their affiliates or subsidiaries will settle, compromise or
consent to the entry of any judgment in any pending or threatened claim, action
or proceeding in respect of which indemnification has been or could be sought
under the indemnification provisions of this Agreement (whether or not Merrill
Lynch or any other Indemnified Party is an actual or potential party to such
claim, action or proceeding), unless such settlement, compromise or consent (a) includes
an unconditional written release, in form and substance satisfactory to Merrill
Lynch and each Indemnified Party, from all liability arising out of such claim,
action or proceeding and (b) does not include any statement as to, or an
admission of, fault, culpability or failure to act by or on behalf of any
Indemnified Party.

 

In the event that an Indemnified Party is requested
or required to appear as a witness in any action brought by or on behalf of or
against Agilent or any of its subsidiaries or affiliates in which such
Indemnified Party is not named as a defendant, World Trade and Agilent agree to
reimburse such Indemnified Party for all reasonable expenses incurred by it in
connection with such Indemnified Party’s appearing and preparing to appear as
such a witness, including, without limitation, the fees and expenses of its
legal counsel.

 

6.             Agilent/World Trade Payment
Obligation.  (a) Agilent and
World Trade jointly and severally agree to pay the Related Amount (as defined
below) to Merrill Lynch or to an affiliate thereof designated by Merrill Lynch,
in addition to any other amounts payable under the Repo Agreement, on each
Related Amount Payment Date (as defined below) in accordance with payment
instructions supplied by Merrill Lynch. 
On or as soon as reasonably practicable following the last day of each
Calculation Period (as defined below), Merrill Lynch shall notify Agilent and
World Trade of the amount payable on the relevant Related Amount Payment Date
(as defined below) and the related payment instructions (the date on which
Merrill Lynch provides such notice, the “Payment Amount Notice Date”).

 

“Related
Amount Payment Date” shall mean each March 19, June 19, September 19
and December 19, commencing on September 19, 2008 and ending on and
including the Repurchase Date, or if such date is not a Business Day, the
immediately succeeding Business Day; provided that if the related Payment
Amount Notice Date has not occurred on or prior to the second Business Day
prior to any such date, then the corresponding Related Amount Payment Date
shall be the second Business Day following such Payment Amount Notice Date.

 

“Related Amount” shall mean, in respect of each Related Amount
Payment Date and the Calculation Period ending on the Period End Date
immediately preceding such Related Amount Payment Date, an amount determined by
Merrill Lynch equal to the excess, if any, of (i) the sum of the Daily
Related Amount for each day during such Calculation Period over (ii) the
Price Differential Payment in respect of such Calculation Period.

 

“Daily
Related Amount” shall mean, as of any date
of determination, an amount equal to (a) the Related Notional Amount on
such date multiplied by (b) the sum of the Base Rate in effect for such
date and the applicable Related Spread, divided by (c) 360.

 

7

 

“Base
Rate” shall mean, as of any date of determination, LIBOR.

 

“Related
Spread” shall mean, as of any date of determination on or prior to July 16,
2008, 52 basis points and, as of any date of determination after July 16,
2008, 235 basis points.

 

“Related
Notional Amount” shall mean, as of any date of determination, an amount equal
to the outstanding balance of the Repurchase Price in effect under the Repo
Agreement for such date.

 

“Calculation
Period” shall mean each period from and including one Period End Date to but
excluding the next following applicable Period End Date, except that (a) the
initial Calculation Period will commence on and include June 14, 2008 and (b) the
final Calculation Period will end on and exclude the Repurchase Date.

 

“Period
End Date” shall mean each March 14, June 14, September 14 and December 14.

 

“LIBOR” with respect to any Calculation Period shall
have the meaning assigned to such term in the Repo Agreement (for a Stated
Price Differential Period coinciding with such Calculation Period).

 

(b)           [reserved]

 

(c)           Any unpaid amounts owing pursuant to
this Section 6 shall accrue interest at the Default Rate (as defined
below) from the applicable due dates. 
For the avoidance of doubt, failure to make any payment required to be
paid pursuant to this Section 6 on the applicable due date shall
constitute a “Material Affiliate Event” within the meaning of the Second Amended
and Restated Certification of Designations in respect of the Purchased
Securities dated as of July 31, 2006 (as amended, restated, modified or
supplemented from time to time, the “Certificate of Designations”) if such
failure is not remedied during the period specified in clause (i) of the
definition of “Material Affiliate Event” set forth in the Certificate of
Designations.  “Default Rate”
means LIBOR plus the Related Spread.  For
purposes of determining the Default Rate, clause (b) of the definition of
“Calculation Period” shall be disregarded.

 

7.             Termination.  This Agreement shall terminate and be of no
further force or effect (except as to Section 5 hereof and unpaid amounts
owing pursuant to Section 6 hereof) upon the earlier to occur of (a) the
fifth anniversary of the date of the Original Related Agreement and (b) the
date on which all of the Purchased Securities are repurchased by World Trade.

 

8.             Assignment
of Counterparty’s Repo Rights and Obligations.  In the event that Merrill Lynch shall have
arranged one or more third-party transferees for the assignment by the
Counterparty to such third-party transferee(s) of all or a portion of the
Counterparty’s Repo Rights and Obligations, Merrill Lynch, Agilent and World
Trade shall enter into one or more new agreements substantially identical to
this Agreement (except as otherwise agreed by the parties) but with respect to
the Repo Rights and Obligations assigned to each such third-party, except that,
with respect to each such new agreement, all references therein to the
Counterparty shall denote the applicable third-party transferee rather than the
Counterparty hereunder.

 

8

 

9.             No
Inconsistent Agreements.  Neither
World Trade nor Agilent has entered into, and neither World Trade nor Agilent
will after the date of this Agreement enter into, any agreement which is
inconsistent with the rights granted to Merrill Lynch in this Agreement or
otherwise conflicts with the provisions hereof. 
The rights granted to Merrill Lynch do not and will not for the term of
this Agreement in any way conflict with the rights granted to the holders of
World Trade’s and Agilent’s other issued and outstanding securities under any
such agreements.

 

10.           Representations.  Each of the parties represents and warrants
that (a) its execution and delivery of this Agreement have been duly
authorized by all requisite action by such party and do not and will not (i) violate
its relevant organizational documents or (ii) violate or conflict with any
law applicable to it, any order or judgment of any court or other agency of
government applicable to it or any of its assets or any contractual restriction
binding on or affecting it or any of its assets, and (b) this Agreement
has been duly executed by it and is enforceable against it.

 

11.           Notices
and Other Communication.  Any notice
or communication required or permitted to be given by any provision of this
Agreement shall be in writing or by facsimile and shall be deemed to have been
delivered, given, and received for all purposes (a) if delivered
personally to the Person or to an officer of the Person to whom the same is
directed, or (b) when the same is actually received (if during the
recipient’s normal business hours if during a Business Day, or, if not, on the
next succeeding Business Day), if sent by facsimile (followed by a hard copy of
the same communication sent by certified mail, postage and charges prepaid), or
by courier or delivery service or by mail, addressed as follows, or to such other
address as such Person may from time to time specify by notice, (i) if to
Agilent or World Trade, at the address of Agilent at 5301 Stevens Creek Blvd,
Santa Clara, CA  95051, Facsimile No.:
(408) 345-8958, Attention: Chief Financial Officer, Treasurer and General
Counsel, with a copy to Ronald S. Gross, Esq., at Jones Day, 222 East 41st
Street New York, New York 10017, Facsimile No.: (212) 755-7306 and (ii) if
to Merrill Lynch, at its address at 4 World Financial Center, 18th Floor, New
York, New York 10080, Facsimile No.: (646) 805-0218, Attention:  Swap Group, with a copy to GMI Counsel,
Merrill Lynch, 4 World Financial Center, 12th Floor, New York, New York 10080,
Facsimile No.: (212) 449-6993, Attention Swaps Legal.

 

12.           Severability.  If any term, provision, covenant, or
condition of this Agreement, or the application thereof to any party or
circumstance, shall be held to be invalid or unenforceable (in whole or in
part) for any reason, the remaining terms, provisions, covenants, and
conditions hereof shall continue in full force and effect as if this Agreement
had been executed with the invalid or unenforceable portion eliminated, so long
as this Agreement as so modified continues to express, without material change,
the original intentions of the parties as to the subject matter of this
Agreement and the deletion of such portion of this Agreement will not
substantially impair the respective benefits or expectations of the parties to
this Agreement.

 

13.           Entire
Agreement.  This Agreement
constitutes the entire agreement and understanding of the parties with respect
to the subject matter hereof, and supersedes all oral communications and prior
writings with respect hereto.

 

14.           Modification.  This Agreement shall not be amended or
modified, except by an instrument in writing signed by each of the parties
hereto.

 

9

 

15.           Governing
Law.  THIS AGREEMENT SHALL BE
GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW
YORK.

 

16.           Consent
to Jurisdiction; Waiver of Venue Objection; Service of Process.  EACH OF AGILENT AND WORLD TRADE HEREBY
IRREVOCABLY SUBMITS TO AND ACCEPTS THE NONEXCLUSIVE JURISDICTION OF ANY FEDERAL
COURT LOCATED IN THE CITY OF NEW YORK OR THE COURTS OF THE STATE OF NEW YORK,
IN EACH CASE, LOCATED IN THE BOROUGH OF MANHATTAN OF THE CITY OF NEW YORK, AND
EACH OF AGILENT AND WORLD TRADE HEREBY IRREVOCABLY AGREES THAT ANY ACTION OR
PROCEEDING AGAINST IT OR AGAINST ITS PROPERTY ARISING OUT OF OR RELATING TO THIS AGREEMENT (AN
“ACTION”) MAY BE HEARD AND DETERMINED IN SUCH FEDERAL OR STATE
COURT.  EACH OF AGILENT AND WORLD TRADE
HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT THAT IT MAY EFFECTIVELY
DO SO, ANY DEFENSE OR OBJECTION (INCLUDING, WITHOUT LIMITATION, ANY DEFENSE OR
OBJECTION TO VENUE BASED ON THE GROUNDS OF FORUM NON CONVENIENS) WHICH IT MAY NOW
OR HEREAFTER HAVE TO THE MAINTENANCE OF ANY ACTION IN ANY SUCH
JURISDICTION.  EACH OF AGILENT AND WORLD
TRADE HEREBY IRREVOCABLY AGREES THAT THE SUMMONS AND COMPLAINT OR ANY OTHER
PROCESS IN ANY ACTION IN ANY JURISDICTION WITHIN THE UNITED STATES MAY BE
SERVED BY MAILING (USING CERTIFIED OR REGISTERED MAIL, POSTAGE PREPAID) TO THE
NOTICE ADDRESS FOR IT SET FORTH HEREIN OR BY HAND DELIVERY TO A PERSON OF
SUITABLE AGE AND DISCRETION AT SUCH ADDRESS. 
EACH OF AGILENT AND WORLD TRADE MAY ALSO BE SERVED IN ANY OTHER
MANNER PERMITTED BY LAW, IN WHICH EVENT ITS TIME TO RESPOND SHALL BE THE TIME
PROVIDED BY LAW.

 

17.           Waiver
of Jury Trial.  EACH OF THE PARTIES
HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION,
PROCEEDING, OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE)
ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OF THE TRANSACTIONS
CONTEMPLATED HEREBY.

 

18.           Counterparts.  This Agreement may be executed in
counterparts, each of which will be deemed an original instrument and all of
which together will constitute one and the same agreement.

 

Signatures follow on next page

 

10

 

IN WITNESS WHEREOF, the undersigned have executed
this Agreement on behalf of the parties as of the date first above written.

 

 

	
   

  	
  AGILENT TECHNOLOGIES, INC.

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
  Name:

  
	
   

  	
   

  	
  Title:

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  AGILENT
  TECHNOLOGIES WORLD TRADE, INC.

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
  Name:

  
	
   

  	
   

  	
  Title:

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  MERRILL
  LYNCH CAPITAL SERVICES, INC.

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
  Name:

  
	
   

  	
   

  	
  Title:

  

 

11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}]]